Hyporetic contains Atenolol 100mg + Chlortalidone 25mg, which is known to be effective for the treatment and control of stroke, high blood pressure and heart failure. Hyporetic comes in a pack of 28 tablets scored for flexibility of dosing. A single tablet of Hyporetic daily gives patient relief, smile and a satisfactory response.


Hypertension: one tablet once daily. There is little or no further drop in blood pressure with increased dosage but, where necessary, another antihypertensive drug such as vasodilator can be added. However, most patients will give a satisfactory response to a single tablet daily of HYPORETIC.

Elderly: Dosage requirements are often lower in this age group.

Children: There is no pediatric experience with HYPORETIC, and for this reason, it is not recommended for use in children.

 Renal Failure: Dosage should be adjusted in case of severe impairment of renal function.


Clinical Pharmacology

Sinus bradycardia, cardiogenic shock, anuria and hepatic disease and disturbance, ischemic heart disease, untreated pheochromocytoma, bronchospastic disease, concomitant use of calcium channel blockers, anesthesia and surgery as well as known hypersensitivity to the product or to sulfonamide-derived drugs.

Products Profile

Download Products Profile



Other Info

Hyporetic is usually well tolerated in properly selected patients. Most adverse effects have been mild and transient. The adverse effects observed for HYPORETIC are essentially the same as those seen with the individual components (Atenolol and Chlortalidone) and they include:

Loss of appetite, dizziness, vertigo, nausea and vomiting, headache, vision changes, paresthesia, diarrhea and constipation, chest pain, wheezing dyspnea, postural hypertension, itching, hyperglycemia, glycosuria, and fatigue.